nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—Rash papular—Hyoscyamine—pancreatitis	0.0253	0.104	CcSEcCtD
Dabrafenib—Rash macular—Hyoscyamine—pancreatitis	0.023	0.0942	CcSEcCtD
Dabrafenib—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.0147	0.0602	CcSEcCtD
Dabrafenib—Rash erythematous—Hyoscyamine—pancreatitis	0.0123	0.0505	CcSEcCtD
Dabrafenib—Rash maculo-papular—Hyoscyamine—pancreatitis	0.00858	0.0351	CcSEcCtD
Dabrafenib—Vision blurred—Propantheline—pancreatitis	0.00759	0.0311	CcSEcCtD
Dabrafenib—Hyponatraemia—Hyoscyamine—pancreatitis	0.00688	0.0282	CcSEcCtD
Dabrafenib—LIMK1—blood—pancreatitis	0.00685	0.131	CbGeAlD
Dabrafenib—Dry mouth—Propantheline—pancreatitis	0.00671	0.0275	CcSEcCtD
Dabrafenib—Dehydration—Hyoscyamine—pancreatitis	0.00637	0.0261	CcSEcCtD
Dabrafenib—Dry skin—Hyoscyamine—pancreatitis	0.00628	0.0257	CcSEcCtD
Dabrafenib—Hypokalaemia—Hyoscyamine—pancreatitis	0.00623	0.0255	CcSEcCtD
Dabrafenib—SIK1—islet of Langerhans—pancreatitis	0.00619	0.119	CbGeAlD
Dabrafenib—Insomnia—Propantheline—pancreatitis	0.00595	0.0244	CcSEcCtD
Dabrafenib—Constipation—Propantheline—pancreatitis	0.00562	0.023	CcSEcCtD
Dabrafenib—Hyperglycaemia—Hyoscyamine—pancreatitis	0.00534	0.0219	CcSEcCtD
Dabrafenib—RAF1—islet of Langerhans—pancreatitis	0.00493	0.0944	CbGeAlD
Dabrafenib—Hypersensitivity—Propantheline—pancreatitis	0.00484	0.0198	CcSEcCtD
Dabrafenib—Asthenia—Propantheline—pancreatitis	0.00472	0.0193	CcSEcCtD
Dabrafenib—SIK1—pancreas—pancreatitis	0.00435	0.0834	CbGeAlD
Dabrafenib—Dizziness—Propantheline—pancreatitis	0.00435	0.0178	CcSEcCtD
Dabrafenib—Arrhythmia—Hyoscyamine—pancreatitis	0.00423	0.0173	CcSEcCtD
Dabrafenib—BRAF—blood—pancreatitis	0.00423	0.081	CbGeAlD
Dabrafenib—Vomiting—Propantheline—pancreatitis	0.00418	0.0171	CcSEcCtD
Dabrafenib—Mental disorder—Hyoscyamine—pancreatitis	0.00415	0.017	CcSEcCtD
Dabrafenib—Rash—Propantheline—pancreatitis	0.00415	0.017	CcSEcCtD
Dabrafenib—Dermatitis—Propantheline—pancreatitis	0.00414	0.017	CcSEcCtD
Dabrafenib—Erythema—Hyoscyamine—pancreatitis	0.00412	0.0169	CcSEcCtD
Dabrafenib—Headache—Propantheline—pancreatitis	0.00412	0.0169	CcSEcCtD
Dabrafenib—Nausea—Propantheline—pancreatitis	0.00391	0.016	CcSEcCtD
Dabrafenib—Vision blurred—Hyoscyamine—pancreatitis	0.00389	0.0159	CcSEcCtD
Dabrafenib—SIK1—blood—pancreatitis	0.00354	0.0678	CbGeAlD
Dabrafenib—RAF1—pancreas—pancreatitis	0.00346	0.0664	CbGeAlD
Dabrafenib—Dry mouth—Hyoscyamine—pancreatitis	0.00343	0.0141	CcSEcCtD
Dabrafenib—Oedema—Hyoscyamine—pancreatitis	0.00337	0.0138	CcSEcCtD
Dabrafenib—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00325	0.0133	CcSEcCtD
Dabrafenib—Hypotension—Hyoscyamine—pancreatitis	0.00315	0.0129	CcSEcCtD
Dabrafenib—Insomnia—Hyoscyamine—pancreatitis	0.00304	0.0125	CcSEcCtD
Dabrafenib—RAF1—digestive system—pancreatitis	0.00296	0.0567	CbGeAlD
Dabrafenib—Fatigue—Hyoscyamine—pancreatitis	0.0029	0.0119	CcSEcCtD
Dabrafenib—Constipation—Hyoscyamine—pancreatitis	0.00288	0.0118	CcSEcCtD
Dabrafenib—RAF1—blood—pancreatitis	0.00282	0.054	CbGeAlD
Dabrafenib—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00275	0.0113	CcSEcCtD
Dabrafenib—Abdominal pain—Hyoscyamine—pancreatitis	0.00266	0.0109	CcSEcCtD
Dabrafenib—Body temperature increased—Hyoscyamine—pancreatitis	0.00266	0.0109	CcSEcCtD
Dabrafenib—Hypersensitivity—Hyoscyamine—pancreatitis	0.00248	0.0102	CcSEcCtD
Dabrafenib—Asthenia—Hyoscyamine—pancreatitis	0.00242	0.00989	CcSEcCtD
Dabrafenib—Pruritus—Hyoscyamine—pancreatitis	0.00238	0.00976	CcSEcCtD
Dabrafenib—Diarrhoea—Hyoscyamine—pancreatitis	0.0023	0.00944	CcSEcCtD
Dabrafenib—Dizziness—Hyoscyamine—pancreatitis	0.00223	0.00912	CcSEcCtD
Dabrafenib—SLCO1B1—digestive system—pancreatitis	0.00221	0.0424	CbGeAlD
Dabrafenib—Vomiting—Hyoscyamine—pancreatitis	0.00214	0.00877	CcSEcCtD
Dabrafenib—Rash—Hyoscyamine—pancreatitis	0.00212	0.0087	CcSEcCtD
Dabrafenib—Dermatitis—Hyoscyamine—pancreatitis	0.00212	0.00869	CcSEcCtD
Dabrafenib—SLCO1B1—blood—pancreatitis	0.00211	0.0404	CbGeAlD
Dabrafenib—Headache—Hyoscyamine—pancreatitis	0.00211	0.00864	CcSEcCtD
Dabrafenib—Nausea—Hyoscyamine—pancreatitis	0.002	0.00819	CcSEcCtD
Dabrafenib—SLC22A8—blood—pancreatitis	0.00164	0.0314	CbGeAlD
Dabrafenib—CYP2C8—blood—pancreatitis	0.0012	0.023	CbGeAlD
Dabrafenib—ABCG2—blood—pancreatitis	0.00117	0.0223	CbGeAlD
Dabrafenib—ABCB1—islet of Langerhans—pancreatitis	0.00101	0.0193	CbGeAlD
Dabrafenib—CYP3A4—digestive system—pancreatitis	0.000853	0.0163	CbGeAlD
Dabrafenib—CYP3A4—blood—pancreatitis	0.000812	0.0156	CbGeAlD
Dabrafenib—ABCB1—pancreas—pancreatitis	0.000707	0.0135	CbGeAlD
Dabrafenib—ABCB1—digestive system—pancreatitis	0.000604	0.0116	CbGeAlD
Dabrafenib—ABCB1—blood—pancreatitis	0.000575	0.011	CbGeAlD
Dabrafenib—RAF1—Developmental Biology—INS—pancreatitis	0.000164	0.000233	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PLA2G1B—pancreatitis	0.000164	0.000233	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—IL6—pancreatitis	0.000163	0.000232	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—IL6—pancreatitis	0.000163	0.000232	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—IL6—pancreatitis	0.000163	0.000232	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GCG—pancreatitis	0.000163	0.000232	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PPP3CA—pancreatitis	0.000163	0.000231	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—IL6—pancreatitis	0.000162	0.00023	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—NRAS—pancreatitis	0.000161	0.000229	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—HRAS—pancreatitis	0.000161	0.000229	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—IL6—pancreatitis	0.000161	0.000228	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—IL6—pancreatitis	0.00016	0.000228	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DRB1—pancreatitis	0.00016	0.000227	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—IL6—pancreatitis	0.00016	0.000227	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—NRAS—pancreatitis	0.000159	0.000226	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—ALB—pancreatitis	0.000159	0.000226	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADH4—pancreatitis	0.000158	0.000225	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—A2M—pancreatitis	0.000158	0.000225	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—KNG1—pancreatitis	0.000158	0.000224	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SST—pancreatitis	0.000158	0.000224	CbGpPWpGaD
Dabrafenib—BRAF—Disease—LPL—pancreatitis	0.000157	0.000224	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TLR2—pancreatitis	0.000157	0.000223	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—DUSP6—pancreatitis	0.000156	0.000222	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—HRAS—pancreatitis	0.000155	0.00022	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—ICAM1—pancreatitis	0.000153	0.000218	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—NRAS—pancreatitis	0.000152	0.000217	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PLA2G1B—pancreatitis	0.000152	0.000215	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—pancreatitis	0.000151	0.000215	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SCT—pancreatitis	0.000151	0.000214	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FGG—pancreatitis	0.000151	0.000214	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CASR—pancreatitis	0.000151	0.000214	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PRSS1—pancreatitis	0.000149	0.000211	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—BDKRB2—pancreatitis	0.000148	0.000211	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—FDX1—pancreatitis	0.000148	0.000211	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CX3CL1—pancreatitis	0.000148	0.00021	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—ALB—pancreatitis	0.000148	0.00021	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—A2M—pancreatitis	0.000146	0.000208	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	0.000146	0.000207	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EGR1—pancreatitis	0.000146	0.000207	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CNR1—pancreatitis	0.000146	0.000207	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALDH2—pancreatitis	0.000145	0.000205	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—pancreatitis	0.000145	0.000205	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCK—pancreatitis	0.000144	0.000205	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MTNR1B—pancreatitis	0.000144	0.000205	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—NRAS—pancreatitis	0.000144	0.000204	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NOD2—pancreatitis	0.000142	0.000202	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD14—pancreatitis	0.000141	0.000201	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PRSS3—pancreatitis	0.000141	0.0002	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PNLIP—pancreatitis	0.000141	0.0002	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	0.000141	0.0002	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GCG—pancreatitis	0.000141	0.0002	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CNR2—pancreatitis	0.00014	0.000199	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—A2M—pancreatitis	0.00014	0.000199	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TACR1—pancreatitis	0.00014	0.000199	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	0.00014	0.000198	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—KRAS—pancreatitis	0.000139	0.000198	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCKAR—pancreatitis	0.000138	0.000196	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	0.000138	0.000196	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADH4—pancreatitis	0.000138	0.000196	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—KRAS—pancreatitis	0.000137	0.000194	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DQA1—pancreatitis	0.000136	0.000193	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—KNG1—pancreatitis	0.000135	0.000192	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALDH2—pancreatitis	0.000134	0.00019	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	0.000133	0.000189	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PDGFA—pancreatitis	0.000133	0.000189	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ALB—pancreatitis	0.000132	0.000188	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCL5—pancreatitis	0.000132	0.000188	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—KRAS—pancreatitis	0.000131	0.000186	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PRSS1—pancreatitis	0.00013	0.000184	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FGA—pancreatitis	0.000128	0.000182	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—LPL—pancreatitis	0.000128	0.000182	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ALB—pancreatitis	0.000128	0.000182	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	0.000127	0.00018	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—XDH—pancreatitis	0.000126	0.00018	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PDGFA—pancreatitis	0.000124	0.000176	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—KRAS—pancreatitis	0.000124	0.000176	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	0.000123	0.000175	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PNLIP—pancreatitis	0.000123	0.000174	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PRSS3—pancreatitis	0.000123	0.000174	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PDGFA—pancreatitis	0.000123	0.000174	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—MDM2—pancreatitis	0.000121	0.000172	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL18—pancreatitis	0.000121	0.000172	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ALB—pancreatitis	0.00012	0.000171	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HGF—pancreatitis	0.00012	0.000171	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PTHLH—pancreatitis	0.000119	0.00017	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SMO—pancreatitis	0.000119	0.00017	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—HRAS—pancreatitis	0.000118	0.000168	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HRAS—pancreatitis	0.000118	0.000168	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ADH1B—pancreatitis	0.000118	0.000168	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FGB—pancreatitis	0.000117	0.000166	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR2A—pancreatitis	0.000116	0.000166	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—HRAS—pancreatitis	0.000116	0.000165	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—MDM2—pancreatitis	0.000116	0.000165	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PPP3CA—pancreatitis	0.000114	0.000162	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL6—pancreatitis	0.000113	0.000161	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL5—pancreatitis	0.000113	0.00016	CbGpPWpGaD
Dabrafenib—BRAF—Disease—INS—pancreatitis	0.000113	0.00016	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ALB—pancreatitis	0.000112	0.000159	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HRAS—pancreatitis	0.000112	0.000159	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—IL6—pancreatitis	0.000111	0.000158	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—LPL—pancreatitis	0.000111	0.000158	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	0.000111	0.000158	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LPL—pancreatitis	0.00011	0.000157	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—XDH—pancreatitis	0.00011	0.000156	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GCG—pancreatitis	0.00011	0.000156	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SST—pancreatitis	0.000109	0.000155	CbGpPWpGaD
Dabrafenib—RAF1—Disease—LPL—pancreatitis	0.000109	0.000155	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DUSP6—pancreatitis	0.000108	0.000154	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL6—pancreatitis	0.000107	0.000152	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CTRB2—pancreatitis	0.000105	0.00015	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—HRAS—pancreatitis	0.000105	0.000149	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SPP1—pancreatitis	0.000104	0.000148	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ADH1B—pancreatitis	0.000103	0.000146	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—BDKRB2—pancreatitis	0.000103	0.000146	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—NRAS—pancreatitis	0.000103	0.000146	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GCG—pancreatitis	0.000101	0.000144	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CRP—pancreatitis	0.000101	0.000144	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CNR1—pancreatitis	0.000101	0.000143	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—IL6—pancreatitis	0.000101	0.000143	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—NRAS—pancreatitis	0.000101	0.000143	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR2A—pancreatitis	9.94e-05	0.000141	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GCG—pancreatitis	9.72e-05	0.000138	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TLR4—pancreatitis	9.69e-05	0.000138	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DRB1—pancreatitis	9.68e-05	0.000138	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	9.61e-05	0.000137	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—pancreatitis	9.53e-05	0.000135	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PLA2G1B—pancreatitis	9.4e-05	0.000134	CbGpPWpGaD
Dabrafenib—BRAF—Disease—MDM2—pancreatitis	9.38e-05	0.000133	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—pancreatitis	9.35e-05	0.000133	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PPARG—pancreatitis	9.34e-05	0.000133	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—KNG1—pancreatitis	9.33e-05	0.000133	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ICAM1—pancreatitis	9.29e-05	0.000132	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LEP—pancreatitis	9.24e-05	0.000131	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—INS—pancreatitis	9.16e-05	0.00013	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—FDX1—pancreatitis	9.13e-05	0.00013	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCL2—pancreatitis	9.1e-05	0.000129	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—A2M—pancreatitis	9.08e-05	0.000129	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—NRAS—pancreatitis	9.05e-05	0.000129	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—pancreatitis	9.05e-05	0.000129	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	8.97e-05	0.000128	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	8.9e-05	0.000126	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TNF—pancreatitis	8.9e-05	0.000126	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—KRAS—pancreatitis	8.82e-05	0.000125	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—NRAS—pancreatitis	8.7e-05	0.000124	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—KRAS—pancreatitis	8.66e-05	0.000123	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—LPL—pancreatitis	8.6e-05	0.000122	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PDGFA—pancreatitis	8.58e-05	0.000122	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADH4—pancreatitis	8.49e-05	0.000121	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ALB—pancreatitis	8.4e-05	0.000119	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALDH2—pancreatitis	8.31e-05	0.000118	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PLA2G1B—pancreatitis	8.19e-05	0.000116	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	8.1e-05	0.000115	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PRSS1—pancreatitis	7.98e-05	0.000113	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—LPL—pancreatitis	7.96e-05	0.000113	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—A2M—pancreatitis	7.91e-05	0.000112	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—INS—pancreatitis	7.9e-05	0.000112	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL5—pancreatitis	7.8e-05	0.000111	CbGpPWpGaD
Dabrafenib—RAF1—Disease—INS—pancreatitis	7.8e-05	0.000111	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—KRAS—pancreatitis	7.79e-05	0.000111	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL2—pancreatitis	7.77e-05	0.00011	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LPL—pancreatitis	7.63e-05	0.000108	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PRSS3—pancreatitis	7.56e-05	0.000107	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PNLIP—pancreatitis	7.56e-05	0.000107	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—HRAS—pancreatitis	7.5e-05	0.000107	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—KRAS—pancreatitis	7.48e-05	0.000106	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—HRAS—pancreatitis	7.36e-05	0.000105	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—pancreatitis	7.35e-05	0.000104	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—pancreatitis	7.28e-05	0.000103	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALDH2—pancreatitis	7.24e-05	0.000103	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SPP1—pancreatitis	7.23e-05	0.000103	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL8—pancreatitis	7.2e-05	0.000102	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—IL6—pancreatitis	7.18e-05	0.000102	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NRAS—pancreatitis	7.04e-05	0.0001	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MDM2—pancreatitis	7.03e-05	9.99e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR2A—pancreatitis	6.88e-05	9.78e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—XDH—pancreatitis	6.78e-05	9.64e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—HRAS—pancreatitis	6.62e-05	9.41e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MDM2—pancreatitis	6.57e-05	9.34e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—pancreatitis	6.54e-05	9.29e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MDM2—pancreatitis	6.49e-05	9.23e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LEP—pancreatitis	6.4e-05	9.09e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	6.37e-05	9.05e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HRAS—pancreatitis	6.36e-05	9.04e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—IL6—pancreatitis	6.34e-05	9.01e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ADH1B—pancreatitis	6.33e-05	8.99e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—pancreatitis	6.31e-05	8.96e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GCG—pancreatitis	6.29e-05	8.95e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARG—pancreatitis	6.28e-05	8.92e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—pancreatitis	6.26e-05	8.89e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—INS—pancreatitis	6.16e-05	8.75e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL8—pancreatitis	6.14e-05	8.73e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—KRAS—pancreatitis	6.06e-05	8.61e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	6.03e-05	8.57e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CASP3—pancreatitis	5.88e-05	8.36e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARG—pancreatitis	5.81e-05	8.26e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—NRAS—pancreatitis	5.77e-05	8.2e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—INS—pancreatitis	5.7e-05	8.1e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALB—pancreatitis	5.64e-05	8.02e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GCG—pancreatitis	5.48e-05	7.79e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—INS—pancreatitis	5.46e-05	7.76e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL2—pancreatitis	5.38e-05	7.64e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NRAS—pancreatitis	5.27e-05	7.49e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALB—pancreatitis	5.23e-05	7.43e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—HRAS—pancreatitis	5.15e-05	7.32e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PLA2G1B—pancreatitis	5.05e-05	7.17e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—KRAS—pancreatitis	4.97e-05	7.06e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LPL—pancreatitis	4.94e-05	7.02e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—pancreatitis	4.94e-05	7.02e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NRAS—pancreatitis	4.93e-05	7e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6—pancreatitis	4.93e-05	7e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—A2M—pancreatitis	4.87e-05	6.93e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NRAS—pancreatitis	4.87e-05	6.92e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—pancreatitis	4.58e-05	6.51e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—pancreatitis	4.57e-05	6.5e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MDM2—pancreatitis	4.55e-05	6.46e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—KRAS—pancreatitis	4.54e-05	6.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—pancreatitis	4.52e-05	6.43e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALDH2—pancreatitis	4.46e-05	6.34e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LPL—pancreatitis	4.3e-05	6.12e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL8—pancreatitis	4.25e-05	6.04e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—KRAS—pancreatitis	4.24e-05	6.03e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HRAS—pancreatitis	4.22e-05	6e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—KRAS—pancreatitis	4.19e-05	5.96e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CASP3—pancreatitis	4.07e-05	5.78e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6—pancreatitis	4.04e-05	5.74e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HRAS—pancreatitis	3.86e-05	5.48e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6—pancreatitis	3.69e-05	5.25e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARG—pancreatitis	3.61e-05	5.13e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HRAS—pancreatitis	3.61e-05	5.12e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—HRAS—pancreatitis	3.56e-05	5.06e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—INS—pancreatitis	3.54e-05	5.03e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6—pancreatitis	3.45e-05	4.9e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NRAS—pancreatitis	3.41e-05	4.85e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6—pancreatitis	3.41e-05	4.85e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GCG—pancreatitis	3.38e-05	4.8e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALB—pancreatitis	3.24e-05	4.61e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—pancreatitis	3.17e-05	4.5e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARG—pancreatitis	3.14e-05	4.46e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—INS—pancreatitis	3.08e-05	4.38e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—KRAS—pancreatitis	2.93e-05	4.17e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—pancreatitis	2.84e-05	4.03e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALB—pancreatitis	2.83e-05	4.01e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LPL—pancreatitis	2.65e-05	3.77e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HRAS—pancreatitis	2.49e-05	3.55e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—pancreatitis	2.47e-05	3.51e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6—pancreatitis	2.39e-05	3.39e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARG—pancreatitis	1.94e-05	2.75e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—INS—pancreatitis	1.9e-05	2.7e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALB—pancreatitis	1.74e-05	2.47e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—pancreatitis	1.52e-05	2.16e-05	CbGpPWpGaD
